Loading...
Loading...
Among the 5 tracked institutional investors we monitor, TAK (TAKEDA PHARMACEUTICAL CO LTD) is held with a combined value of $287.71M across 15,551,337 shares. The largest holder is FMR LLC with a position worth $131.82M (0.01% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings.
Total Institutional Value
$287.71M
Total Shares Held
15,551,337
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $131.82M | 0.01% | +75.4% |
| 2 | BlackRock, Inc. | $58.83M | 0.00% | +16.3% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | $55.36M | 0.09% | +14.2% |
| 4 | CITADEL ADVISORS LLC | $40.12M | 0.01% | +10.3% |
| 5 | VANGUARD GROUP INC | $1.59M | 0.00% | New |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of TAK with a position worth $131.82M, representing 0.01% of their portfolio. In total, 5 institutional investors hold TAK with a combined value of $287.71M.
In the most recent quarter, 1 fund opened a new position in TAK. Additionally, 4 increased their holdings.
Institutional investors hold $287.71M worth of TAK stock across 5 positions. The largest institutional holder is FMR LLC with $131.82M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TAK, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TAK positions.